Last week, readers were most interested in a rumor about a possible sale of QuidelOrtho's point-of-care business, which sent its stock soaring.

The project, which is an initiative of the Quest Diagnostics Foundation, aims to expand healthcare access in the area, including through no-cost laboratory testing.

The guidelines address items like interpretation of results that may be affected by gender-affirming hormone therapy and improving electronic health record practices.

The agency cleared more than a dozen assays and instruments for microbiology, molecular biology, clinical chemistry, and other testing.

The PCR-based panels detect up to 22 of the most common bacteria, viruses, and parasites associated with gastroenteritis.

Last week, readers were most interested in a story about Achieve Diagnostics buying the pharmacogenomic assets of H&M Molecular Diagnostics.

The company aims to complete the international development and validation of the test, as well as to obtain European regulatory approval and commercialize it as a service and a kit.

The company will conduct a prospective, multicenter study enrolling approximately 954 men with elevated PSA levels who are scheduled for a prostate biopsy.

The firm currently offers its HerResolve multiomic test for endometriosis that looks at seven biomarkers, including microRNAs ...

The planned trial will investigate Eledon's tegoprubart, a therapy designed to prevent organ rejection in kidney transplantation.

Verici Dx said on Wednesday that its Tutivia lab-developed test for acute kidney transplant rejection risk has been approved by the New York State Department of Health (NYSDOH). With the approval ...